Cargando…

Seroprevalence of SARS-CoV-2: Insights into the epidemiology of the pandemic

AIM: This study aimed to assess the seroprevalence of SARS-CoV-2 and disease symptoms in Malakand, Pakistan. MATERIALS & METHOD: 623 samples with suspected SARS-CoV-2 were collected from different regions of Malakand and analyzed to detect SARS-CoV-2 IgG antibodies using ELISA. RESULTS: 306 (49....

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Amjad, Waqar, Muhammad, Akram, Ayesha, Rafique, Shazia, Rehman, Gauhar, Idrees, Muhammad, Halim, Sobia Ahsan, Waqas, Muhammad, Uddin, Jalal, Gojayev, Anar, Khan, Ajmal, Al-Harrasi, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234367/
https://www.ncbi.nlm.nih.gov/pubmed/37300952
http://dx.doi.org/10.1016/j.jiph.2023.05.036
_version_ 1785052476774285312
author Ali, Amjad
Waqar, Muhammad
Akram, Ayesha
Rafique, Shazia
Rehman, Gauhar
Idrees, Muhammad
Halim, Sobia Ahsan
Waqas, Muhammad
Uddin, Jalal
Gojayev, Anar
Khan, Ajmal
Al-Harrasi, Ahmed
author_facet Ali, Amjad
Waqar, Muhammad
Akram, Ayesha
Rafique, Shazia
Rehman, Gauhar
Idrees, Muhammad
Halim, Sobia Ahsan
Waqas, Muhammad
Uddin, Jalal
Gojayev, Anar
Khan, Ajmal
Al-Harrasi, Ahmed
author_sort Ali, Amjad
collection PubMed
description AIM: This study aimed to assess the seroprevalence of SARS-CoV-2 and disease symptoms in Malakand, Pakistan. MATERIALS & METHOD: 623 samples with suspected SARS-CoV-2 were collected from different regions of Malakand and analyzed to detect SARS-CoV-2 IgG antibodies using ELISA. RESULTS: 306 (49.1%) 0 f 623 patients were anti-SARS-CoV-2 IgG reactive, with a higher prevalence in males (75%) than females (25%). In this study, we enrolled two groups, subjects working in a non-medical setting and subjects working in a medical setting. Clinical symptoms were statistically linked with SARS-CoV-2. Four weeks of follow-up analysis of IgG titers in health care workers showed an increase in IgG antibodies titer. CONCLUSION: This study gives insights into the community-based spread of SARS-CoV-2 infection, associated immunity, and herd immunity in the studied population. This study can provide insights to the government about early vaccination of this population as most of the population is not yet vaccinated.
format Online
Article
Text
id pubmed-10234367
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
record_format MEDLINE/PubMed
spelling pubmed-102343672023-06-01 Seroprevalence of SARS-CoV-2: Insights into the epidemiology of the pandemic Ali, Amjad Waqar, Muhammad Akram, Ayesha Rafique, Shazia Rehman, Gauhar Idrees, Muhammad Halim, Sobia Ahsan Waqas, Muhammad Uddin, Jalal Gojayev, Anar Khan, Ajmal Al-Harrasi, Ahmed J Infect Public Health Article AIM: This study aimed to assess the seroprevalence of SARS-CoV-2 and disease symptoms in Malakand, Pakistan. MATERIALS & METHOD: 623 samples with suspected SARS-CoV-2 were collected from different regions of Malakand and analyzed to detect SARS-CoV-2 IgG antibodies using ELISA. RESULTS: 306 (49.1%) 0 f 623 patients were anti-SARS-CoV-2 IgG reactive, with a higher prevalence in males (75%) than females (25%). In this study, we enrolled two groups, subjects working in a non-medical setting and subjects working in a medical setting. Clinical symptoms were statistically linked with SARS-CoV-2. Four weeks of follow-up analysis of IgG titers in health care workers showed an increase in IgG antibodies titer. CONCLUSION: This study gives insights into the community-based spread of SARS-CoV-2 infection, associated immunity, and herd immunity in the studied population. This study can provide insights to the government about early vaccination of this population as most of the population is not yet vaccinated. The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2023-08 2023-06-01 /pmc/articles/PMC10234367/ /pubmed/37300952 http://dx.doi.org/10.1016/j.jiph.2023.05.036 Text en © 2023 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Ali, Amjad
Waqar, Muhammad
Akram, Ayesha
Rafique, Shazia
Rehman, Gauhar
Idrees, Muhammad
Halim, Sobia Ahsan
Waqas, Muhammad
Uddin, Jalal
Gojayev, Anar
Khan, Ajmal
Al-Harrasi, Ahmed
Seroprevalence of SARS-CoV-2: Insights into the epidemiology of the pandemic
title Seroprevalence of SARS-CoV-2: Insights into the epidemiology of the pandemic
title_full Seroprevalence of SARS-CoV-2: Insights into the epidemiology of the pandemic
title_fullStr Seroprevalence of SARS-CoV-2: Insights into the epidemiology of the pandemic
title_full_unstemmed Seroprevalence of SARS-CoV-2: Insights into the epidemiology of the pandemic
title_short Seroprevalence of SARS-CoV-2: Insights into the epidemiology of the pandemic
title_sort seroprevalence of sars-cov-2: insights into the epidemiology of the pandemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234367/
https://www.ncbi.nlm.nih.gov/pubmed/37300952
http://dx.doi.org/10.1016/j.jiph.2023.05.036
work_keys_str_mv AT aliamjad seroprevalenceofsarscov2insightsintotheepidemiologyofthepandemic
AT waqarmuhammad seroprevalenceofsarscov2insightsintotheepidemiologyofthepandemic
AT akramayesha seroprevalenceofsarscov2insightsintotheepidemiologyofthepandemic
AT rafiqueshazia seroprevalenceofsarscov2insightsintotheepidemiologyofthepandemic
AT rehmangauhar seroprevalenceofsarscov2insightsintotheepidemiologyofthepandemic
AT idreesmuhammad seroprevalenceofsarscov2insightsintotheepidemiologyofthepandemic
AT halimsobiaahsan seroprevalenceofsarscov2insightsintotheepidemiologyofthepandemic
AT waqasmuhammad seroprevalenceofsarscov2insightsintotheepidemiologyofthepandemic
AT uddinjalal seroprevalenceofsarscov2insightsintotheepidemiologyofthepandemic
AT gojayevanar seroprevalenceofsarscov2insightsintotheepidemiologyofthepandemic
AT khanajmal seroprevalenceofsarscov2insightsintotheepidemiologyofthepandemic
AT alharrasiahmed seroprevalenceofsarscov2insightsintotheepidemiologyofthepandemic